呼吸系统疾病专栏

扬州地区新型冠状病毒delta变异株感染54例儿童临床特点分析

  • 吕媛 ,
  • 舒桂华 ,
  • 侯玮玮 ,
  • 路星星 ,
  • 袁敏 ,
  • 王月媛 ,
  • 陶月红
展开
  • 扬州大学附属苏北人民医院(江苏省苏北人民医院)儿科(江苏扬州 225000)

收稿日期: 2021-08-31

  网络出版日期: 2022-04-07

Clinical features of 54 children infected with SARS-CoV-2 delta variant in Yangzhou area

  • Yuan LYU ,
  • Guihua SHU ,
  • Weiwei HOU ,
  • Xingxing LU ,
  • Min YUAN ,
  • Yueyuan WANG ,
  • Yuehong TAO
Expand
  • Department of Pediatrics, Northern Jiangsu People’s Hospital Affiliated to Yangzhou University, Yangzhou 225000, Jiangsu, China

Received date: 2021-08-31

  Online published: 2022-04-07

摘要

目的 探讨儿童新型冠状病毒(SARS-CoV-2)delta变异株感染的临床特点及其与成人的异同点。方法 回顾性分析扬州市54例确诊SARS-CoV-2 delta变异株感染儿童的临床资料,并与同期确诊的青壮年成人患者比较。结果 儿童组54例,男35例、女19例,平均年龄(8.1±3.4)岁。成人组37例,男23例、女14例,平均年龄(33.4±7.6)岁。与成人组相比,儿童组轻型比例较高,疫苗接种比例较低,出现呼吸系统症状的比例较低,CK-MB较高,CRP和IL-6水平较低,入院时新型冠状病毒特异性抗体IgM及IgG的滴度均较低,差异有统计学意义(P<0.05)。两组患者均未予抗生素、糖皮质激素治疗,以中药、体位治疗及对症处理为主,预后均良好,儿童组从起病到临床症状消失时间为4.0(2.0~7.0)d,成人组为7.0(4.2~10.8)d,两组间比较差异有统计学意义(P<0.01);感染后儿童组的新型冠状病毒特异性抗体IgM、IgG的峰值均低于成人组,差异有统计学意义(P<0.05)。结论 儿童也是SARS-CoV-2 delta变异株的易感人群,感染后以轻型多见,更易发生心肌损伤,疾病恢复较成人更快。

本文引用格式

吕媛 , 舒桂华 , 侯玮玮 , 路星星 , 袁敏 , 王月媛 , 陶月红 . 扬州地区新型冠状病毒delta变异株感染54例儿童临床特点分析[J]. 临床儿科杂志, 2022 , 40(4) : 252 -257 . DOI: 10.12372/jcp.2022.21e1264

Abstract

Objective To investigate the clinical characteristics of SARS-CoV-2 delta variant in children and the similarities and differences between children and adults.Methods The clinical data of 54 children infected with SARS-COV-2 delta variant in Yangzhou were retrospectively analyzed and were compared with those of adults who were diagnosed in the same period.Results There were 35 boys and 19 girls in the children group and the mean age was (8.1±3.4) years. In the adult group, there were 37 patients (23 boys and 14 girls), and the mean age was (33.4±7.6) years. Compared with the adult group, the children group had a higher proportion of mild cases, a lower proportion of vaccination, a lower proportion of respiratory symptoms, a higher level of CK-MB, a lower level of CRP and IL-6, and a lower titer of SARS-CoV-2 IgG and IgM antibodies on admission, and the differences were statistically significant (P<0.05). No antibiotics or glucocorticoids were given in 2 groups. The patients were mainly treated with traditional Chinese medicine, posture therapy and symptomatic treatment, and the prognosis were good. The time from onset to disappearance of clinical symptoms was 4.0 (2.0-7.0) days in the children group and 7.0 (4.2-10.8) days in the adult group, and the difference between the two groups was statistically significant (P<0.01). The peak values of SARS-CoV-2 IgG and IgM antibodies in the children group were lower than those in the adult group, and the differences were statistically significant (P<0.05).Conclusions Children are also susceptible to the SARS-COV-2 delta variant, with a higher proportion of mild infection. Furthermore, children are more likely to have myocardial injury and recover faster than adults.

参考文献

[1] 中华预防医学会新型冠状病毒肺炎防控专家组. 新型冠状病毒肺炎流行病学特征的最新认识[J]. 中华流行病学杂志, 2020, 41(2):139-144.
[2] Maltezou HC, Magaziotou I, Dedoukou X, et al. Children and adolescents with SARS-CoV-2 infection: epidemiology, clinical course and viral loads[J]. Pediatr Infect Dis J, 2020, 39(12):e388-e392.
[3] 蒋荣猛, 谢正德, 姜毅, 等. 儿童新型冠状病毒感染诊断、治疗和预防专家共识(第三版)[J]. 中华实用儿科临床杂志, 2021, 36(10):721-732.
[4] 中华人民共和国国家卫生健康委员会. 新型冠状病毒肺炎诊疗方案(试行第八版修订版)[J]. 中华临床感染病杂志, 2021, 14(2):81-88.
[5] Zimmermann P, Curtis N. Coronavirus infections in children including COVID-19: an overview of the epidemiology, clinical features, diagnosis, treatment and prevention options in children[J]. Pediatr Infect Dis J, 2020, 39(5):355-368.
[6] Wu H, Zhu H, Yuan C, et al. Clinical and immune features of hospitalized pediatric patients with coronavirus disease 2019 (COVID-19) in Wuhan, China[J]. JAMA Netw Open, 2020, 3(6):e2010895.
[7] Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study[J]. Lancet, 2020, 395(10229):1054-1062.
[8] Opel DJ, Diekema DS, Ross LF. Should we mandate a COVID-19 vaccine for children?[J]. JAMA Pediatr, 2021, 175(2):125-126.
[9] Liguoro I, Pilotto C, Bonanni M, et al. SARS-COV-2 infection in children and newborns: a systematic review[J]. Eur J Pediatr, 2020, 179(7):1029-1046.
[10] 易兰芬, 邱梅, 文红霞. 新型冠状病毒感染儿童心肌损伤的研究[J]. 临床儿科杂志, 2020, 38(12):905-907.
[11] Iba T, Levy JH, Levi M, et al. Coagulopathy in COVID-19[J]. J Thromb Haemost, 2020, 18(9):2103-2109.
[12] Boehme AK, Doyle K, Thakur KT, et al. Disorders of consciousness in hospitalized patients with COVID-19: the role of the systemic inflammatory response syndrome[J]. Neurocrit Care, 2022, 36(1):89-96.
[13] Mukund K, Mathee K, Subramaniam S. Plasmin cascade mediates thrombotic events in SARS-CoV-2 infection via complement and platelet-activating systems[J]. IEEE Open J Eng Med Biol, 2020, 1:220-227.
文章导航

/